Protara Therapeutics TARA
NASDAQ TARA
$3.94 -0.03 (-0.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Protara Therapeutics (TARA) EPS (Diluted) (2013 - 2026)

Analysis

Protara Therapeutics (TARA) EPS (Diluted) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 12.23
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 7.15
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.33 Bn 44.33 Bn - -3.06
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.15
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.06
10 Protara Therapeutics 241.28 Mn 241.28 Mn - -0.36
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.36
Mar 31, 2026 -0.31
Dec 31, 2025 -0.41
Sep 30, 2025 -0.31
Jun 30, 2025 -0.35
Mar 31, 2025 -0.30
Dec 31, 2024 -0.64
Sep 30, 2024 -0.50
Jun 30, 2024 -0.45
Mar 31, 2024 -0.97
Dec 31, 2023 -0.90
Sep 30, 2023 -0.87
Jun 30, 2023 -2.60
Mar 31, 2023 0.80
Dec 31, 2022 -3.46
Sep 30, 2022 -0.68
Jun 30, 2022 -2.67
Mar 31, 2022 0.96
Dec 31, 2021 -0.91
Sep 30, 2021 -0.96